Advertisement
Research Article Free access | 10.1172/JCI111690
Find articles by Weber, S. in: JCI | PubMed | Google Scholar
Find articles by Zuckerman, J. in: JCI | PubMed | Google Scholar
Find articles by Bostwick, D. in: JCI | PubMed | Google Scholar
Find articles by Bensch, K. in: JCI | PubMed | Google Scholar
Find articles by Sikic, B. in: JCI | PubMed | Google Scholar
Find articles by Raffin, T. in: JCI | PubMed | Google Scholar
Published January 1, 1985 - More info
Human small cell lung carcinoma (SCLC) cells have been shown to contain significant levels of a bombesin-immunoreactive peptide. The 27-amino acid peptide, gastrin releasing peptide (GRP), has recently been shown to be responsible for the bombesin-like immunoreactivity found in SCLC cells. Among four lung cancer cell lines examined in vitro, GRP exhibited mitogenic activity for two SCLC subtypes, but not for a squamous carcinoma or adenocarcinoma lung cell line. The mitogenicity of the GRP molecule has been isolated to the carboxyterminal fragment, designated GRP 14-27, which is in part homologous to bombesin. The aminoterminal fragment, GRP 1-16, is no homologous to bombesin and exhibits no mitogenic activity. Thus, GRP may be an important growth regulating or autocrine factor in human SCLC.
Click on an image below to see the page. View PDF of the complete article